Kim J, Park M, Jeong W, Lee HW, Lee G, Lee KS, Park SW, Choi J
FDA-approved semaglutide formulations (Wegovy*, Ozempic)
If at least 48 hours have passed since your previous dose, you are within the approved minimum interval for semaglutide
Moreover, the role of endogenous glucagon-like peptide 1 (GLP-1) in the body is reviewed, including neuronally synthesized GLP-1, with a focus on how recent research developments may point towards therapeutic utility of GLP-1RAs in neuro-ophthalmology
10.1038/nm919 36 EngJ.KleinmanW
[PMID: 10447101] PubMed record related to this compound for laboratory literature review